Profile of specific antibodies to the SARS-CoV-2

In this work, we studied the profile of IgM and IgG antibody responses to SARS-CoV-2 in 32 patients with COVID-19 from day 1 to day 24. IgM remained measurable for a much shorter period than IgG, suggesting that IgG antibody may represent the primary immune response.

Detalles Bibliográficos
Autores principales: Mou, Danlei, Feng, Huahua, Cao, Ruiyuan, Weng, Xing, Zhao, Lizhe, Yang, Lingling, Jin, Ronghua, Chen, Weijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Microbiology Society 2021
Materias:
Clinical Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346729/
https://www.ncbi.nlm.nih.gov/pubmed/33734961
http://dx.doi.org/10.1099/jmm.0.001335
_version_ 1783734941305012224
author Mou, Danlei
Feng, Huahua
Cao, Ruiyuan
Weng, Xing
Zhao, Lizhe
Yang, Lingling
Jin, Ronghua
Chen, Weijun
author_facet Mou, Danlei
Feng, Huahua
Cao, Ruiyuan
Weng, Xing
Zhao, Lizhe
Yang, Lingling
Jin, Ronghua
Chen, Weijun
author_sort Mou, Danlei
collection PubMed
description In this work, we studied the profile of IgM and IgG antibody responses to SARS-CoV-2 in 32 patients with COVID-19 from day 1 to day 24. IgM remained measurable for a much shorter period than IgG, suggesting that IgG antibody may represent the primary immune response.
format Online
Article
Text
id pubmed-8346729
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Microbiology Society
record_format MEDLINE/PubMed
spelling pubmed-83467292021-08-09 Profile of specific antibodies to the SARS-CoV-2 Mou, Danlei Feng, Huahua Cao, Ruiyuan Weng, Xing Zhao, Lizhe Yang, Lingling Jin, Ronghua Chen, Weijun J Med Microbiol Clinical Microbiology In this work, we studied the profile of IgM and IgG antibody responses to SARS-CoV-2 in 32 patients with COVID-19 from day 1 to day 24. IgM remained measurable for a much shorter period than IgG, suggesting that IgG antibody may represent the primary immune response. Microbiology Society 2021-03-18 /pmc/articles/PMC8346729/ /pubmed/33734961 http://dx.doi.org/10.1099/jmm.0.001335 Text en © 2021 The Authors https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License. The Microbiology Society waived the open access fees for this article.
spellingShingle Clinical Microbiology
Mou, Danlei
Feng, Huahua
Cao, Ruiyuan
Weng, Xing
Zhao, Lizhe
Yang, Lingling
Jin, Ronghua
Chen, Weijun
Profile of specific antibodies to the SARS-CoV-2
title Profile of specific antibodies to the SARS-CoV-2
title_full Profile of specific antibodies to the SARS-CoV-2
title_fullStr Profile of specific antibodies to the SARS-CoV-2
title_full_unstemmed Profile of specific antibodies to the SARS-CoV-2
title_short Profile of specific antibodies to the SARS-CoV-2
title_sort profile of specific antibodies to the sars-cov-2
topic Clinical Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346729/
https://www.ncbi.nlm.nih.gov/pubmed/33734961
http://dx.doi.org/10.1099/jmm.0.001335
work_keys_str_mv AT moudanlei profileofspecificantibodiestothesarscov2
AT fenghuahua profileofspecificantibodiestothesarscov2
AT caoruiyuan profileofspecificantibodiestothesarscov2
AT wengxing profileofspecificantibodiestothesarscov2
AT zhaolizhe profileofspecificantibodiestothesarscov2
AT yanglingling profileofspecificantibodiestothesarscov2
AT jinronghua profileofspecificantibodiestothesarscov2
AT chenweijun profileofspecificantibodiestothesarscov2

Ejemplares similares